webinar register page

Webinar banner
The Patient Equation by Glen de Vries: Virtual Book Release Party
Glen deVries is co-founder and co-CEO of Medidata, a Dassault Systèmes company, one of NYC’s (and the world's) pioneering healthcare technology companies. Glen is the author of a new book, “The Patient Equation: The Precision Medicine Revolution in the Age of COVID-19 and Beyond,” which chronicles how the breakthroughs in new data-driven approaches to treatment, and the algorithms working in the background, are increasing our understanding of disease at both molecular and holistic, patient levels.

Join us for a one-one-one discussion with Glen on his vision of staying ahead of the curve in life sciences and healthcare, including:
• How our industry integrates new knowledge, new data and new technologies to realize the promise of precision medicine
• How patient equations built with new data and advanced models lead to better health outcomes and personalized care
• How COVID-19 put a spotlight on the fragility of health care and accelerated the need for change -- where everyone connecting and working together toward a common goal is leading to rapid medical advancements

Royalties from the sale of the book will be donated to Conquer CancerⓇ, the ASCO Foundation. Glen and Medidata have been long-time supporters of NYC Health Business Leaders, and we are proud to help him celebrate the release of his new book.

We are raffling autographed copies of the book for attendees. If you'd like to enter the raffle, be sure to enter your mailing address when registering.

Sep 29, 2020 01:00 PM in Eastern Time (US and Canada)

Webinar logo
* Required information
Loading

Speakers

Glen de Vries
Co-CEO and Co-founder @Medidata Solutions
Glen de Vries is co-CEO and co-founder of Medidata, the most-used platform for clinical trials around the world. Medidata has powered tens of thousands of clinical trials, with millions of patients and billions of patient records. In 2019, in one of the largest healthcare technology acquisitions in history, Medidata became part of Dassault Systèmes. Glen has been driving Medidata’s mission since the company’s inception in 1999, “powering smarter treatments and healthier people” by advancing pharmaceutical business transformation with technology, non-traditional ways of thinking, and industry collaboration. Glen’s publications have appeared in Applied Clinical Trials, Cancer, The Journal of Urology, Molecular Diagnostics, and other journals. He serves as a trustee of Carnegie Mellon University, and is the author of The Patient Equation (de Vries & Blachman, 2020).